Elmarakby, Ahmed A <br/><br/>
ETA receptor blockade attenuates hypertension and decreases reactive oxygen species in ETB receptor-deficient rats.  [electronic resource] 

 -  Journal of cardiovascular pharmacology  Nov 2004 
 - S7-10 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4023 
<br/><br/><label>Standard No.: </label>10.1097/01.fjc.0000166205.66555.40  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Animals, Genetically Modified<br/>Antihypertensive Agents--pharmacology<br/>Aorta--drug effects<br/>Atrasentan<br/>Blood Pressure--drug effects<br/>Dinoprost--analogs & derivatives<br/>Disease Models, Animal<br/>Down-Regulation<br/>Endothelin A Receptor Antagonists<br/>Endothelins--blood<br/>Hypertension--chemically induced<br/>Male<br/>Pyrrolidines--pharmacology<br/>Rats<br/>Receptor, Endothelin A--metabolism<br/>Receptor, Endothelin B--deficiency<br/>Sodium Chloride, Dietary<br/>Superoxides--metabolism<br/>Time Factors